1.
Anderlini P, Przepiorka D, Champlin R, Korbling M: Biological and clinical effects of granulocyte colony stimulating factor in normal individuals. Blood 1996;88:2819–2825.
2.
Kawano Y, Takaue Y, Watanabe T, Watanabe A, Iwai A, Kuroda Y: Peripheral blood stem cell mobilisation with granulocyte colony stimulating factor and a harvesting procedure in pediatric donors. Bone Marrow Transplant 1998;21(suppl 3):S32–34.
3.
Cleaver SA, Goldman JM: Use of G-CSF to mobilise PBSC in normal healthy donors – An international survey. Bone Marrow Transplant 1998;21(suppl 3):S29–31.
4.
Faucher C, Fortanier, Viens P, Le Corroller AG, Chabannon C, Camerlo J, Novakovitch G, Gastaut JA, Maraninchi D, Moatti JP, Blaise D: Clinical and economic comparison of lenograstim-primed blood cells (BC) and bonemarrow (BM) allogeneic transplantation. Bone Marrow Transplant 1998;21(suppl 3):S92–98.
5.
Knudsen LM, Hanssen SW, Daugard G, Jarlbaek L, Agerbaek M, Jensen L, Skovsgard T, Hanssen F, Johnsen HE: Comparison of rh G-CSF primed bone marrow and blood stem cell autograft: An analysis of engraftment in malignant lymphomas and solid tumours. Eur J Haematol 1998;61/4:229–234.
6.
Slowman S, Darrielson C, Graves V, Kotylo P, Broun R, McCarthy L: Administration of GM/G-CSF. Prior to bone marrow harvest increases collection of CD 34+ cells. Prog Clin Biol Res 1994;389:363–369.
7.
Lowenthal RM, Sullivan SA, Parker N: Marsden KA: G-CSF. Primed bone marrow cells for autologous transplantation. Lancet 1996;347:1125.
8.
Hansen PB, Knudsen H, Gaarsdal F, Jensen L, Ralfkiafer E; Johnsen HE: Short term in vivo priming of bone marrow haematopoiesis with rh G-CSF, rh GM-CSF or rh IL-3 before marrow harvest expands myelopoiesis but does not improve engraftment capability. Bone Marrow Transplant 1995;16:373–379.
9.
Isola LM, Scigliano E, Skerrett D, Shank B, Ross V, Najfeld D, Fruchtman S: A pilot study of allogeneic bone marrow transplantation using related donors stimulated with G-CSF. Bone Marrow Transplant 1997;20:1033–1037.
10.
Weaver CH, Hazelton B, Birch R, Palmer P, Allen C, Schwartzberg L, West W: An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after administration of myeloablative therapy. Blood 1995;86:3961–3969.
11.
Fritsch G, Stimpfl M, Kurz M, Leitner A, Printz D, Buchinger P, Hoecker P, Gadner H: Characterisation of haemopoietic stem cells. NY Acad Sci 1995;770:42–52.
1999
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or...
1999
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.